CBUS
Cibus Global Ltd. Class A (CBUS)
Healthcare • NASDAQ • $1.44-4.00%
- Symbol
- CBUS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $1.44
- Daily Change
- -4.00%
- Market Cap
- $116.53M
- Trailing P/E
- N/A
- Forward P/E
- -7.20
- 52W High
- $4.19
- 52W Low
- $1.09
- Analyst Target
- $14.67
- Dividend Yield
- N/A
- Beta
- 1.66
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Company websiteResearch CBUS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.